Temporal proteomic analysis of HIV infection reveals remodelling of the host phosphoproteome by lentiviral Vif variants

eLife

Volumn 5, Issue September2016, 2016, Pages

  Greenwood, Edward J D ^a   Matheson, Nicholas J ^a   Wals, Kim ^a   van den Boomen, Dick J H ^a   Antrobus, Robin ^a   Williamson, James C ^a   Lehner, Paul J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AURORA KINASE; CELL PROTEIN; LENTIVIRUS VECTOR; PHOSPHOPEPTIDE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEASOME; SHORT HAIRPIN RNA; VIF PROTEIN; PHOSPHOPROTEIN; PROTEOME; VIF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DEGRADATION KINETICS; FLOW CYTOMETRY; GENE EXPRESSION; GENE SILENCING; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; ISOTOPE LABELING; MASS SPECTROMETRY; MOLECULAR CLONING; PHOSPHOPROTEOMICS; PROTEOMICS; QUANTITATIVE STUDY; TRANSGENE; VALIDATION PROCESS; VIRUS GENOME; VIRUS RELEASE; CELL CULTURE; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS; METABOLISM; PATHOLOGY; PHYSIOLOGY; TIME FACTOR;

CELLS, CULTURED; HIV; HIV INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; PHOSPHOPROTEINS; PROTEOME; PROTEOMICS; TIME FACTORS; VIF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84994585684     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.18296     Document Type: Article

References (128)

1. Ai Y, Zhu D, Wang C, Su C, Ma J, Ma J, Wang X. 2014. Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation. Journal of Virology 88:12112-12122. doi: 10.1128/JVI.01924-14
2. Araínga M, Guo D, Wiederin J, Ciborowski P, McMillan J, Gendelman HE. 2015. Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages. Retrovirology 12:5. doi: 10.1186/s12977-014-0133-5
3. Asano E, Hasegawa H, Hyodo T, Ito S, Maeda M, Takahashi M, Hamaguchi M, Senga T. 2013. The Aurora-B-mediated phosphorylation of SHCBP1 regulates cytokinetic furrow ingression. Journal of Cell Science 126: 3263-3270. doi: 10.1242/jcs.124875
4. Ayinde D, Casartelli N, Schwartz O. 2012. Restricting HIV the SAMHD1 way: through nucleotide starvation. Nature Reviews. Microbiology 10:675-680. doi: 10.1038/nrmicro2862
5. Baldauf HM, Pan X, Erikson E, Schmidt S, Daddacha W, Burggraf M, Schenkova K, Ambiel I, Wabnitz G, Gramberg T, Panitz S, Flory E, Landau NR, Sertel S, Rutsch F, Lasitschka F, Kim B, Kö nig R, Fackler OT, Keppler OT. 2012. SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. Nature Medicine 18:1682-1687. doi: 10.1038/nm.2964
6. Bastos RN, Cundell MJ, Barr FA. 2014. KIF4A and PP2A-B56 form a spatially restricted feedback loop opposing Aurora B at the anaphase central spindle. The Journal of Cell Biology 207:683-693. doi: 10.1083/jcb.201409129
7. Bensimon A, Aebersold R, Shiloh Y. 2011. Beyond ATM: the protein kinase landscape of the DNA damage response. FEBS Letters 585:1625-1639. doi: 10.1016/j.febslet.2011.05.013
8. Bergeron JR, Huthoff H, Veselkov DA, Beavil RL, Simpson PJ, Matthews SJ, Malim MH, Sanderson MR. 2010. The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complex. PLoS Pathogens 6:e1000925. doi: 10.1371/journal.ppat.1000925
9. Besnard-Guerin C, Belaïdouni N, Lassot I, Segeral E, Jobart A, Marchal C, Benarous R. 2004. HIV-1 Vpu sequesters beta-transducin repeat-containing protein (betaTrCP) in the cytoplasm and provokes the accumulation of beta-catenin and other SCFbetaTrCP substrates. The Journal of Biological Chemistry 279:788-795. doi: 10.1074/jbc.M308068200
10. Binka M, Ooms M, Steward M, Simon V. 2012. The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H. Journal of Virology 86:49-59. doi: 10.1128/JVI.06082-11
11. Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, Souza B, Schryver B, Flanagan P, Clairvoyant F, Ginther C, Chan CS, Novotny M, Slamon DJ, Plowman GD. 1998. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. The EMBO Journal 17:3052-3065. doi: 10.1093/emboj/17.11.3052
12. Blas-Rus N, Bustos-Morán E, Pérez de Castro I, de Carcer G, Borroto A, Camafeita E, Jorge I, Vázquez J, Alarcón B, Malumbres M, Martín-Cófreces NB, Sánchez-Madrid F. 2016. Aurora A drives early signalling and vesicle dynamics during T-cell activation. Nature Communications 7:11389. doi: 10.1038/ncomms11389
13. Chan EY, Qian WJ, Diamond DL, Liu T, Gritsenko MA, Monroe ME, Camp DG, Smith RD, Katze MG. 2007. Quantitative analysis of human immunodeficiency virus type 1-infected CD4+ cell proteome: dysregulated cell cycle progression and nuclear transport coincide with robust virus production. Journal of Virology 81:7571-7583. doi: 10.1128/JVI.00288-07
14. Chan EY, Sutton JN, Jacobs JM, Bondarenko A, Smith RD, Katze MG. 2009. Dynamic host energetics and cytoskeletal proteomes in human immunodeficiency virus type 1-infected human primary CD4 cells: analysis by multiplexed label-free mass spectrometry. Journal of Virology 83:9283-9295. doi: 10.1128/JVI.00814-09
15. Chang ST, Sova P, Peng X, Weiss J, Law GL, Palermo RE, Katze MG. 2011. Next-generation sequencing reveals HIV-1-mediated suppression of T cell activation and RNA processing and regulation of noncoding RNA expression in a CD4+ T cell line. mBio 2:e00134-11. doi: 10.1128/mBio.00134-11
16. de Hoon MJ, Imoto S, Nolan J, Miyano S. 2004. Open source clustering software. Bioinformatics 20:1453-1454. doi: 10.1093/bioinformatics/bth078
17. Dephoure N, Zhou C, Villén J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP. 2008. A quantitative atlas of mitotic phosphorylation. PNAS 105:10762-10767. doi: 10.1073/pnas.0805139105
18. Desimmie BA, Delviks-Frankenberrry KA, Burdick RC, Qi D, Izumi T, Pathak VK. 2014. Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all. Journal of Molecular Biology 426:1220-1245. doi: 10.1016/j.jmb.2013.10.033
19. Ding L, Gu H, Gao X, Xiong S, Zheng B. 2015. Aurora kinase a regulates m1 macrophage polarization and plays a role in experimental autoimmune encephalomyelitis. Inflammation 38:800-811. doi: 10.1007/s10753-014-9990-2
20. Doehle BP, Schäfer A, Cullen BR. 2005. Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif. Virology 339:281-288. doi: 10.1016/j.virol.2005.06.005
21. Duggal NK, Emerman M. 2012. Evolutionary conflicts between viruses and restriction factors shape immunity. Nature Reviews. Immunology 12:687-695. doi: 10.1038/nri3295
22. Eisen MB, Spellman PT, Brown PO, Botstein D. 1998. Cluster analysis and display of genome-wide expression patterns. PNAS 95:14863-14868. doi: 10.1073/pnas.95.25.14863
23. Espert A, Uluocak P, Bastos RN, Mangat D, Graab P, Gruneberg U. 2014. PP2A-B56 opposes Mps1 phosphorylation of Knl1 and thereby promotes spindle assembly checkpoint silencing. The Journal of Cell Biology 206:833-842. doi: 10.1083/jcb.201406109
24. Foley GE, Handler AH, Lynch PM, Wolman SR, Stulberg CS, Eagle H. 1965. Loss of neoplastic properties in vitro. II. Observations on KB sublines. Cancer Research 25:1254-1261.
25. Fouchier RA, Simon JH, Jaffe AB, Malim MH. 1996. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins. Journal of Virology 70:8263-8269.
26. Fribourgh JL, Nguyen HC, Wolfe LS, Dewitt DC, Zhang W, Yu XF, Rhoades E, Xiong Y. 2014. Core binding factor beta plays a critical role by facilitating the assembly of the Vif-cullin 5 E3 ubiquitin ligase. Journal of Virology 88:3309-3319. doi: 10.1128/JVI.03824-13
27. García-Expósito L, Ziglio S, Barroso-González J, de Armas-Rillo L, Valera MS, Zipeto D, Machado JD, Valenzuela-Fernández A. 2013. Gelsolin activity controls efficient early HIV-1 infection. Retrovirology 10:39. doi: 10.1186/1742-4690-10-39
28. Gifford RJ, Katzourakis A, Tristem M, Pybus OG, Winters M, Shafer RW. 2008. A transitional endogenous lentivirus from the genome of a basal primate and implications for lentivirus evolution. PNAS 105:20362-20367. doi: 10.1073/pnas.0807873105
29. Gifford RJ. 2012. Viral evolution in deep time: lentiviruses and mammals. Trends in Genetics 28:89-100. doi: 10.1016/j.tig.2011.11.003
30. Goujon C, Moncorgé O, Bauby H, Doyle T, Ward CC, Schaller T, HuéS, Barclay WS, Schulz R, Malim MH. 2013. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature 502:559-562. doi: 10.1038/nature12542
31. Haller C, Mü ller B, Fritz JV, Lamas-Murua M, Stolp B, Pujol FM, Keppler OT, Fackler OT. 2014. HIV-1 Nef and Vpu are functionally redundant broad-spectrum modulators of cell surface receptors, including tetraspanins. Journal of Virology 88:14241-14257. doi: 10.1128/JVI.02333-14
32. Haverland NA, Fox HS, Ciborowski P. 2014. Quantitative proteomics by SWATH-MS reveals altered expression of nucleic acid binding and regulatory proteins in HIV-1-infected macrophages. Journal of Proteome Research 13:2109-2119. doi: 10.1021/pr4012602
33. Hedges SB, Marin J, Suleski M, Paymer M, Kumar S. 2015. Tree of life reveals clock-like speciation and diversification. Molecular Biology and Evolution 32:835-845. doi: 10.1093/molbev/msv037
34. Hengeveld RC, Hertz NT, Vromans MJ, Zhang C, Burlingame AL, Shokat KM, Lens SM. 2012. Development of a chemical genetic approach for human aurora B kinase identifies novel substrates of the chromosomal passenger complex. Molecular & Cellular Proteomics 11:47-59. doi: 10.1074/mcp.M111.013912
35. Hornbeck PV, Zhang B, Murray B, Kornhauser JM, Latham V, Skrzypek E. 2015. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Research 43:D512-520. doi: 10.1093/nar/gku1267
36. Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik-Brodacka M, Srivastava S, Florens L, Washburn MP, Skowronski J. 2011. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474:658-661. doi: 10.1038/nature10195
37. Hrecka K, Hao C, Shun MC, Kaur S, Swanson SK, Florens L, Washburn MP, Skowronski J. 2016. HIV-1 and HIV-2 exhibit divergent interactions with HLTF and UNG2 DNA repair proteins. PNAS 113:E3921-E3930. doi: 10.1073/pnas.1605023113
38. Huang da W, Sherman BT, Lempicki RA. 2009a. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Research 37:1-13. doi: 10.1093/nar/gkn923
39. Huang da W, Sherman BT, Lempicki RA. 2009b. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols 4:44-57. doi: 10.1038/nprot.2008.211
40. Hultquist JF, Binka M, LaRue RS, Simon V, Harris RS. 2012. Vif proteins of human and simian immunodeficiency viruses require cellular CBFb to degrade APOBEC3 restriction factors. Journal of Virology 86:2874-2877. doi: 10.1128/JVI.06950-11
41. Huthoff H, Malim MH. 2007. Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation. Journal of Virology 81:3807-3815. doi: 10.1128/JVI.02795-06
42. Imai K, Okamoto T. 2006. Transcriptional repression of human immunodeficiency virus type 1 by AP-4. The Journal of Biological Chemistry 281:12495-12505. doi: 10.1074/jbc.M511773200
43. Jager S, Kim DY, Hultquist JF, Shindo K, LaRue RS, Kwon E, Li M, Anderson BD, Yen L, Stanley D. 2012. Vif hijacks CBF-b to degrade APOBEC3G and promote HIV-1 infection. Nature 481:371-375. doi: 10.1038/nature10693
44. Jin J, Ang XL, Shirogane T, Wade Harper J. 2005. Identification of substrates for F-box proteins. Methods in Enzymology 399:287-309. doi: 10.1016/S0076-6879(05)99020-4
45. Jolly C, Kashefi K, Hollinshead M, Sattentau QJ. 2004. HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. The Journal of Experimental Medicine 199:283-293. doi: 10.1084/jem.20030648
46. Jowett JB, Planelles V, Poon B, Shah NP, Chen ML, Chen IS. 1995. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. Journal of Virology 69:6304-6313.
47. Kane JR, Stanley DJ, Hultquist JF, Johnson JR, Mietrach N, Binning JM, Jónsson SR, Barelier S, Newton BW, Johnson TL, Franks-Skiba KE, Li M, Brown WL, Gunnarsson HI, Adalbjornsdóttir A, Fraser JS, Harris RS, Andrésdóttir V, Gross JD, Krogan NJ. 2015. Lineage-specific viral hijacking of non-canonical E3 ubiquitin ligase cofactors in the evolution of Vif anti-APOBEC3 activity. Cell Reports 11:1236-1250. doi: 10.1016/j.celrep.2015.04.038
48. Karn J, Stoltzfus CM. 2012. Transcriptional and posttranscriptional regulation of HIV-1 gene expression. Cold Spring Harbor Perspectives in Medicine 2:a006916. doi: 10.1101/cshperspect.a006916
49. Katzourakis A, Tristem M, Pybus OG, Gifford RJ. 2007. Discovery and analysis of the first endogenous lentivirus. PNAS 104:6261-6265. doi: 10.1073/pnas.0700471104
50. Kauko O, Laajala TD, Jumppanen M, Hintsanen P, Suni V, Haapaniemi P, Corthals G, Aittokallio T, Westermarck J, Imanishi SY. 2015. Label-free quantitative phosphoproteomics with novel pairwise abundance normalization reveals synergistic RAS and CIP2A signaling. Scientific Reports 5:13099. doi: 10.1038/srep13099
51. Keckesova Z, Ylinen LM, Towers GJ, Gifford RJ, Katzourakis A. 2009. Identification of a RELIK orthologue in the European hare (Lepus europaeus) reveals a minimum age of 12 million years for the lagomorph lentiviruses. Virology 384:7-11. doi: 10.1016/j.virol.2008.10.045
52. Kettenbach AN, Schweppe DK, Faherty BK, Pechenick D, Pletnev AA, Gerber SA. 2011. Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells. Science Signaling 4:rs5. doi: 10.1126/scisignal.2001497
53. Khoury GA, Baliban RC, Floudas CA. 2011. Proteome-wide post-translational modification statistics: frequency analysis and curation of the swiss-prot database. Scientific Reports 1:90. doi: 10.1038/srep00090
54. Kim DY, Kwon E, Hartley PD, Crosby DC, Mann S, Krogan NJ, Gross JD. 2013. CBFb stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression. Molecular Cell 49:632-644. doi: 10.1016/j.molcel.2012.12.012
55. Kraft-Terry SD, Engebretsen IL, Bastola DK, Fox HS, Ciborowski P, Gendelman HE. 2011. Pulsed stable isotope labeling of amino acids in cell culture uncovers the dynamic interactions between HIV-1 and the monocyte-derived macrophage. Journal of Proteome Research 10:2852-2862. doi: 10.1021/pr200124j
56. Kruse T, Zhang G, Larsen MS, Lischetti T, Streicher W, Kragh Nielsen T, Bjørn SP, Nilsson J. 2013. Direct binding between BubR1 and B56-PP2A phosphatase complexes regulate mitotic progression. Journal of Cell Science 126:1086-1092. doi: 10.1242/jcs.122481
57. Laguette N, Brégnard C, Hue P, Basbous J, Yatim A, Larroque M, Kirchhoff F, Constantinou A, Sobhian B, Benkirane M. 2014. Premature activation of the SLX4 complex by Vpr promotes G2/M arrest and escape from innate immune sensing. Cell 156:134-145. doi: 10.1016/j.cell.2013.12.011
58. Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, Ségéral E, Yatim A, Emiliani S, Schwartz O, Benkirane M. 2011. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474:654-657. doi: 10.1038/nature10117
59. Lahouassa H, Blondot ML, Chauveau L, Chougui G, Morel M, Leduc M, Guillonneau F, Ramirez BC, Schwartz O, Margottin-Goguet F. 2016. HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages. PNAS 113:5311-5316. doi: 10.1073/pnas.1600485113
60. Lahouassa H, Daddacha W, Hofmann H, Ayinde D, Logue EC, Dragin L, Bloch N, Maudet C, Bertrand M, Gramberg T, Pancino G, Priet S, Canard B, Laguette N, Benkirane M, Transy C, Landau NR, Kim B, Margottin-Goguet F. 2012. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nature Immunology 13:223-228. doi: 10.1038/ni.2236
61. Lai M, Zimmerman ES, Planelles V, Chen J. 2005. Activation of the ATR pathway by human immunodeficiency virus type 1 Vpr involves its direct binding to chromatin in vivo. Journal of Virology 79:15443-15451. doi: 10.1128/JVI.79.24.15443-15451.2005
62. Larue RS, Lengyel J, Jónsson SR, Andrésdóttir V, Harris RS. 2010. Lentiviral Vif degrades the APOBEC3Z3/APOBEC3H protein of its mammalian host and is capable of cross-species activity. Journal of Virology 84:8193-8201. doi: 10.1128/JVI.00685-10
63. Letko M, Silvestri G, Hahn BH, Bibollet-Ruche F, Gokcumen O, Simon V, Ooms M. 2013. Vif proteins from diverse primate lentiviral lineages use the same binding site in APOBEC3G. Journal of Virology 87:11861-11871. doi: 10.1128/JVI.01944-13
64. Lin XH, Walter J, Scheidtmann K, Ohst K, Newport J, Walter G. 1998. Protein phosphatase 2A is required for the initiation of chromosomal DNA replication. PNAS 95:14693-14698. doi: 10.1073/pnas.95.25.14693
65. Lu YL, Spearman P, Ratner L. 1993. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. Journal of Virology 67:6542-6550.
66. Ly T, Ahmad Y, Shlien A, Soroka D, Mills A, Emanuele MJ, Stratton MR, Lamond AI. 2014. A proteomic chronology of gene expression through the cell cycle in human myeloid leukemia cells. eLife 3:e01630. doi: 10.7554/eLife.01630
67. Malim MH, Bieniasz PD. 2012. HIV restriction factors and mechanisms of evasion. Cold Spring Harbor Perspectives in Medicine 2:a006940. doi: 10.1101/cshperspect.a006940
68. Malim MH. 2009. APOBEC proteins and intrinsic resistance to HIV-1 infection. Philosophical Transactions of the Royal Society B 364:675-687. doi: 10.1098/rstb.2008.0185
69. Matheson NJ, Peden AA, Lehner PJ. 2014. Antibody-free magnetic cell sorting of genetically modified primary human CD4+ T cells by one-step streptavidin affinity purification. PloS One 9:e111437. doi: 10.1371/journal.pone.0111437
70. Matheson NJ, Sumner J, Wals K, Rapiteanu R, Weekes MP, Vigan R, Weinelt J, Schindler M, Antrobus R, Costa AS, Frezza C, Clish CB, Neil SJ, Lehner PJ. 2015. Cell surface proteomic map of HIV infection reveals antagonism of amino acid metabolism by Vpu and Nef. Cell Host & Microbe 18:409-423. doi: 10.1016/j.chom.2015.09.003
71. McCright B, Rivers AM, Audlin S, Virshup DM. 1996. The B56 family of protein phosphatase 2A (PP2A) regulatory subunits encodes differentiation-induced phosphoproteins that target PP2A to both nucleus and cytoplasm. The Journal of Biological Chemistry 271:22081-22089. doi: 10.1074/jbc.271.36.22081
72. Miyagi E, Kao S, Yedavalli V, Strebel K. 2014. CBFb enhances de novo protein biosynthesis of its binding partners HIV-1 Vif and RUNX1 and potentiates the Vif-induced degradation of APOBEC3G. Journal of Virology 88:4839-4852. doi: 10.1128/JVI.03359-13
73. Mootha VK, Bunkenborg J, Olsen JV, Hjerrild M, Wisniewski JR, Stahl E, Bolouri MS, Ray HN, Sihag S, Kamal M, Patterson N, Lander ES, Mann M. 2003. Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria. Cell 115:629-640. doi: 10.1016/S0092-8674(03)00926-7
74. Nakai-Murakami C, Shimura M, Kinomoto M, Takizawa Y, Tokunaga K, Taguchi T, Hoshino S, Miyagawa K, Sata T, Kurumizaka H, Yuo A, Ishizaka Y. 2007. HIV-1 Vpr induces ATM-dependent cellular signal with enhanced homologous recombination. Oncogene 26:477-486. doi: 10.1038/sj.onc.1209831
75. Navare AT, Sova P, Purdy DE, Weiss JM, Wolf-Yadlin A, Korth MJ, Chang ST, Proll SC, Jahan TA, Krasnoselsky AL, Palermo RE, Katze MG. 2012. Quantitative proteomic analysis of HIV-1 infected CD4+ T cells reveals an early host response in important biological pathways: protein synthesis, cell proliferation, and T-cell activation. Virology 429:37-46. doi: 10.1016/j.virol.2012.03.026
76. Norbury C, Nurse P. 1992. Animal cell cycles and their control. Annual Review of Biochemistry 61:441-470. doi: 10.1146/annurev.bi.61.070192.002301
77. Notredame C, Higgins DG, Heringa J. 2000. T-Coffee: A novel method for fast and accurate multiple sequence alignment. Journal of Molecular Biology 302:205-217. doi: 10.1006/jmbi.2000.4042
78. Ochoa D, Jonikas M, Lawrence RT, El Debs B, Selkrig J, Typas A, Villen J, Santos S, Beltrao P. 2016. An atlas of human kinase regulation. bioR xiv. doi: 10.1101/067900
79. Pan Q, Rong L, Zhao X, Liang C. 2009. Fragile X mental retardation protein restricts replication of human immunodeficiency virus type 1. Virology 387:127-135. doi: 10.1016/j.virol.2009.02.006
80. Pathak S, De Souza GA, Salte T, Wiker HG, Asjö B. 2009. HIV induces both a down-regulation of IRAK-4 that impairs TLR signalling and an up-regulation of the antibiotic peptide dermcidin in monocytic cells. Scandinavian Journal of Immunology 70:264-276. doi: 10.1111/j.1365-3083.2009.02299.x
81. Paxton W, Connor RI, Landau NR. 1993. Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis. Journal of Virology 67:7229-7237.
82. Pollard VW, Malim MH. 1998. The HIV-1 Rev protein. Annual Review of Microbiology 52:491-532. doi: 10.1146/annurev.micro.52.1.491
83. Randow F, Lehner PJ. 2009. Viral avoidance and exploitation of the ubiquitin system. Nature Cell Biology 11: 527-534. doi: 10.1038/ncb0509-527
84. Rasheed S, Yan JS, Hussain A, Lai B. 2009. Proteomic characterization of HIV-modulated membrane receptors, kinases and signaling proteins involved in novel angiogenic pathways. Journal of Translational Medicine 7:75. doi: 10.1186/1479-5876-7-75
85. Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D. 1997. GeneCards: integrating information about genes, proteins and diseases. Trends in Genetics 13:163. doi: 10.1016/S0168-9525(97)01103-7
86. Ringrose JH, Jeeninga RE, Berkhout B, Speijer D. 2008. Proteomic studies reveal coordinated changes in T-cell expression patterns upon infection with human immunodeficiency virus type 1. Journal of Virology 82:4320-4330. doi: 10.1128/JVI.01819-07
87. Roshal M, Kim B, Zhu Y, Nghiem P, Planelles V. 2003. Activation of the ATR-mediated DNA damage response by the HIV-1 viral protein R. The Journal of Biological Chemistry 278:25879-25886. doi: 10.1074/jbc.M303948200
88. Ruediger R, Van Wart Hood JE, Mumby M, Walter G. 1991. Constant expression and activity of protein phosphatase 2A in synchronized cells. Molecular and Cellular Biology 11:4282-4285. doi: 10.1128/MCB.11.8.4282
89. Saldanha AJ. 2004. Java Treeview-extensible visualization of microarray data. Bioinformatics 20:3246-3248. doi: 10.1093/bioinformatics/bth349
90. Salter JD, Lippa GM, Belashov IA, Wedekind JE. 2012. Core-binding factor b increases the affinity between human Cullin 5 and HIV-1 Vif within an E3 ligase complex. Biochemistry 51:8702-8704. doi: 10.1021/bi301244z
91. Santamaria A, Wang B, Elowe S, Malik R, Zhang F, Bauer M, Schmidt A, Silljé HH, Körner R, Nigg EA. 2011. The Plk1-dependent phosphoproteome of the early mitotic spindle. Molecular & Cellular Proteomics 10:M110-4457. doi: 10.1074/mcp.M110.004457
92. Sargan DR, Bennet ID, Cousens C, Roy DJ, Blacklaws BA, Dalziel RG, Watt NJ, McConnell I. 1991. Nucleotide sequence of EV1, a British isolate of maedi-visna virus. The Journal of General Virology 72:1893-1903. doi: 10.1099/0022-1317-72-8-1893
93. Schneider CA, Rasband WS, Eliceiri KW. 2012. NIH Image to ImageJ: 25 years of image analysis. Nature Methods 9:671-675. doi: 10.1038/nmeth.2089
94. Schröfelbauer B, Yu Q, Zeitlin SG, Landau NR. 2005. Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases. Journal of Virology 79:10978-10987. doi: 10.1128/JVI.79.17.10978-10987.2005
95. Schwartz S, Felber BK, Fenyö EM, Pavlakis GN. 1990. Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs. Journal of Virology 64:5448-5456.
96. Schwämmle V, León IR, Jensen ON. 2013. Assessment and improvement of statistical tools for comparative proteomics analysis of sparse data sets with few experimental replicates. Journal of Proteome Research 12: 3874-3883. doi: 10.1021/pr400045u
97. Seeling JM, Miller JR, Gil R, Moon RT, White R, Virshup DM. 1999. Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A. Science 283:2089-2091. doi: 10.1126/science.283.5410.2089
98. Sheehy AM, Gaddis NC, Choi JD, Malim MH. 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-650. doi: 10.1038/nature00939
99. Sherrill-Mix S, Ocwieja KE, Bushman FD. 2015. Gene activity in primary T cells infected with HIV89.6: intron retention and induction of genomic repeats. Retrovirology 12:79. doi: 10.1186/s12977-015-0205-1
100. Shrivastava S, Trivedi J, Mitra D. 2016. Gene expression profiling reveals Nef induced deregulation of lipid metabolism in HIV-1 infected T cells. Biochemical and Biophysical Research Communications 472:169-174. doi: 10.1016/j.bbrc.2016.02.089
101. Simon JH, Fouchier RA, Southerling TE, Guerra CB, Grant CK, Malim MH. 1997. The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells. Journal of Virology 71:5259-5267.
102. Simon V, Bloch N, Landau NR. 2015. Intrinsic host restrictions to HIV-1 and mechanisms of viral escape. Nature Immunology 16:546-553. doi: 10.1038/ni.3156
103. Smith JL, Pathak VK. 2010. Identification of specific determinants of human APOBEC3F, APOBEC3C, and APOBEC3DE and African green monkey APOBEC3F that interact with HIV-1 Vif. Journal of Virology 84:12599-12608. doi: 10.1128/JVI.01437-10
104. Specht A, DeGottardi MQ, Schindler M, Hahn B, Evans DT, Kirchhoff F. 2008. Selective downmodulation of HLA-A and -B by Nef alleles from different groups of primate lentiviruses. Virology 373:229-237. doi: 10.1016/j.virol.2007.11.019
105. Stopak K, de Noronha C, Yonemoto W, Greene WC. 2003. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Molecular Cell 12:591-601. doi: 10.1016/S1097-2765(03)00353-8
106. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. PNAS 102:15545-15550. doi: 10.1073/pnas.0506580102
107. Sugden SM, Bego MG, Pham TN, Cohen é A. 2016. Remodeling of the host cell plasma membrane by HIV-1 Nef and Vpu: A strategy to ensure viral fitness and persistence. Viruses 8:67. doi: 10.3390/v8030067
108. Taus T, Köcher T, Pichler P, Paschke C, Schmidt A, Henrich C, Mechtler K. 2011. Universal and confident phosphorylation site localization using phosphoRS. Journal of Proteome Research 10:5354-5362. doi: 10.1021/pr200611n
109. Taylor HE, Simmons GE, Mathews TP, Khatua AK, Popik W, Lindsley CW, D’Aquila RT, Brown HA. 2015. Phospholipase D1 couples CD4+ T cell activation to c-Myc-dependent deoxyribonucleotide pool expansion and HIV-1 replication. PLoS Pathogens 11:e1004864. doi: 10.1371/journal.ppat.1004864
110. van ‘t Wout AB, Swain JV, Schindler M, Rao U, Pathmajeyan MS, Mullins JI, Kirchhoff F. 2005. Nef induces multiple genes involved in cholesterol synthesis and uptake in human immunodeficiency virus type 1-infected T cells. Journal of Virology 79:10053-10058. doi: 10.1128/JVI.79.15.10053-10058.2005
111. van den Boomen DJ, Timms RT, Grice GL, Stagg HR, Skødt K, Dougan G, Nathan JA, Lehner PJ. 2014. TMEM129 is a Derlin-1 associated ERAD E3 ligase essential for virus-induced degradation of MHC-I. PNAS 111:11425-11430. doi: 10.1073/pnas.1409099111
112. Vasiliver-Shamis G, Cho MW, Hioe CE, Dustin ML. 2009. Human immunodeficiency virus type 1 envelope gp120-induced partial T-cell receptor signaling creates an F-actin-depleted zone in the virological synapse. Journal of Virology 83:11341-11355. doi: 10.1128/JVI.01440-09
113. Vassena L, Giuliani E, Matusali G, Cohené A, Doria M. 2013. The human immunodeficiency virus type 1 Vpr protein upregulates PVR via activation of the ATR-mediated DNA damage response pathway. The Journal of General Virology 94:2664-2669. doi: 10.1099/vir.0.055541-0
114. Vizcaíno JA, Côté RG, Csordas A, Dianes JA, Fabregat A, Foster JM, Griss J, Alpi E, Birim M, Contell J, O’Kelly G, Schoenegger A, Ovelleiro D, Perez-Riverol Y, Reisinger F, Ríos D, Wang R, Hermjakob H. 2013. The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Research 41: D1063-D1069. doi: 10.1093/nar/gks1262
115. Weekes MP, Tomasec P, Huttlin EL, Fielding CA, Nusinow D, Stanton RJ, Wang EC, Aicheler R, Murrell I, Wilkinson GW, Lehner PJ, Gygi SP. 2014. Quantitative temporal viromics: an approach to investigate host-pathogen interaction. Cell 157:1460-1472. doi: 10.1016/j.cell.2014.04.028
116. Welburn JP, Vleugel M, Liu D, Yates JR, Lampson MA, Fukagawa T, Cheeseman IM. 2010. Aurora B phosphorylates spatially distinct targets to differentially regulate the kinetochore-microtubule interface. Molecular Cell 38:383-392. doi: 10.1016/j.molcel.2010.02.034
117. Wilkinson GW, Davison AJ, Tomasec P, Fielding CA, Aicheler R, Murrell I, Seirafian S, Wang EC, Weekes M, Lehner PJ, Wilkie GS, Stanton RJ. 2015. Human cytomegalovirus: taking the strain. Medical Microbiology and Immunology 204:273-284. doi: 10.1007/s00430-015-0411-4
118. Wiśniewski JR, Zougman A, Nagaraj N, Mann M. 2009. Universal sample preparation method for proteome analysis. Nature Methods 6:359-362. doi: 10.1038/nmeth.1322
119. Worobey M, Telfer P, Souquière S, Hunter M, Coleman CA, Metzger MJ, Reed P, Makuwa M, Hearn G, Honarvar S, Roques P, Apetrei C, Kazanji M, Marx PA. 2010. Island biogeography reveals the deep history of SIV. Science 329:1487. doi: 10.1126/science.1193550
120. Wu C, Barbezange C, McConnell I, Blacklaws BA. 2008. Mapping and characterization of visna/maedi virus cytotoxic T-lymphocyte epitopes. The Journal of General Virology 89:2586-2596. doi: 10.1099/vir.0.2008/002634-0
121. Wu R, Dephoure N, Haas W, Huttlin EL, Zhai B, Sowa ME, Gygi SP. 2011. Correct interpretation of comprehensive phosphorylation dynamics requires normalization by protein expression changes. Molecular & Cellular Proteomics 10:M111.009654. doi: 10.1074/mcp.M111.009654
122. Xu P, Raetz EA, Kitagawa M, Virshup DM, Lee SH. 2013. BUBR1 recruits PP2A via the B56 family of targeting subunits to promote chromosome congression. Biology Open 2:479-486. doi: 10.1242/bio.20134051
123. Yang J, Phiel C. 2010. Functions of B56-containing PP2As in major developmental and cancer signaling pathways. Life Sciences 87:659-666. doi: 10.1016/j.lfs.2010.10.003
124. Yoshikawa R, Izumi T, Nakano Y, Yamada E, Moriwaki M, Misawa N, Ren F, Kobayashi T, Koyanagi Y, Sato K. 2016. Small ruminant lentiviral Vif proteins commonly utilize cyclophilin A, an evolutionarily and structurally conserved protein, to degrade ovine and caprine APOBEC3 proteins. Microbiology and Immunology 60:427-436. doi: 10.1111/1348-0421.12387
125. Yu CT, Hsu JM, Lee YC, Tsou AP, Chou CK, Huang CY. 2005. Phosphorylation and stabilization of HURP by Aurora-A: implication of HURP as a transforming target of Aurora-A. Molecular and Cellular Biology 25:5789-5800. doi: 10.1128/MCB.25.14.5789-5800.2005
126. Zhang H, Zhou Y, Alcock C, Kiefer T, Monie D, Siliciano J, Li Q, Pham P, Cofrancesco J, Persaud D, Siliciano RF. 2004. Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1. Journal of Virology 78:1718-1729. doi: 10.1128/JVI.78.4.1718-1729.2004
127. Zhang J, Wu J, Wang W, Wu H, Yu B, Wang J, Lv M, Wang X, Zhang H, Kong W, Yu X. 2014. Role of cullin-elonginB-elonginC E3 complex in bovine immunodeficiency virus and maedi-visna virus Vif-mediated degradation of host A3Z2-Z3 proteins. Retrovirology 11:77. doi: 10.1186/s12977-014-0077-9
128. Zhang W, Du J, Evans SL, Yu Y, Yu XF. 2012. T-cell differentiation factor CBF-b regulates HIV-1 Vif-mediated evasion of host restriction. Nature 481:376-379. doi: 10.1038/nature10718